Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Klebsiella pneumoniae surface antigens are a collection of immunogenic molecules located on the bacterial exterior, primarily consisting of the capsular polysaccharide (K antigen), lipopolysaccharide (O antigen), and various outer membrane proteins (OMPs) (Podschun & Ullmann, 1998). These components are essential for the pathogen's survival and virulence within the host; the capsule acts as a protective shield against phagocytosis and complement-mediated lysis, while the O-antigen provides resistance to the bactericidal activity of serum (Bengoechea & Sa Pessoa, 2019). As therapeutic targets, these antigens are the focus of vaccine development and monoclonal antibody therapies designed to treat infections caused by multi-drug resistant (MDR) strains (Choi et al., 2020). For example, the monoclonal antibody AR-401 targets the O-antigen to promote opsonophagocytic killing by host immune cells (Aridis Pharmaceuticals). A significant challenge in targeting these antigens is their high structural diversity, particularly the existence of over 77 distinct K-serotypes, which requires the use of multivalent or broadly cross-reactive therapeutic agents (Vaxcyte, 2023).
Enhancement of opsonophagocytosis and neutralization of bacterial virulence factors
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Klebsiella pneumoniae surface antigen.